LLY

758.12

+2.89%↑

JNJ

151.16

+1.45%↑

UNH

291.21

+7.79%↑

ABBV

182.59

+1.45%↑

NVO

64.13

-2.91%↓

LLY

758.12

+2.89%↑

JNJ

151.16

+1.45%↑

UNH

291.21

+7.79%↑

ABBV

182.59

+1.45%↑

NVO

64.13

-2.91%↓

LLY

758.12

+2.89%↑

JNJ

151.16

+1.45%↑

UNH

291.21

+7.79%↑

ABBV

182.59

+1.45%↑

NVO

64.13

-2.91%↓

LLY

758.12

+2.89%↑

JNJ

151.16

+1.45%↑

UNH

291.21

+7.79%↑

ABBV

182.59

+1.45%↑

NVO

64.13

-2.91%↓

LLY

758.12

+2.89%↑

JNJ

151.16

+1.45%↑

UNH

291.21

+7.79%↑

ABBV

182.59

+1.45%↑

NVO

64.13

-2.91%↓

Search

Tilray Inc

Open

SectorHealthcare

0.45 7.14

Overview

Share price change

24h

Current

Min

0.42

Max

0.45

Key metrics

By Trading Economics

Income

-708M

-794M

Sales

-118M

186M

EPS

-0.869

Profit margin

-427.136

Employees

2,650

EBITDA

-585M

-626M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+111.36% upside

Dividends

By Dow Jones

Next Earnings

28 Jul 2025

Market Stats

By TradingEconomics

Market Cap

-562M

467M

Previous open

-6.69

Previous close

0.45

News Sentiment

By Acuity

60%

40%

325 / 382 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

Tilray Inc Chart

Past performance is not a reliable indicator of future results.

Related News

16 May 2024, 18:13 UTC

Major Market Movers

Canopy Growth, Tilray Shares Rise After DOJ Proposes Marijuana Reclassification

8 Apr 2025, 12:06 UTC

Market Talk

Tilray Reckons Sales Won't Be Dented by Tariffs -- Market Talk

Peer Comparison

Price change

Tilray Inc Forecast

Price Target

By TipRanks

111.36% upside

12 Months Forecast

Average 0.93 USD  111.36%

High 1.5 USD

Low 0.6 USD

Based on 6 Wall Street analysts offering 12 month price targets forTilray Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

6 ratings

2

Buy

4

Hold

0

Sell

Technical Score

By Trading Central

0.421 / 0.4898Support & Resistance

Short Term

Weak Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

No Evidence

Sentiment

By Acuity

325 / 382 Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Tilray Inc

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Beverage Alcohol, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Charlotte's Web, Montauk Brewing, Shock Top, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point Brewing, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Bake Sale, The Batch, HEXO, Alpine Beer Company, Green Flash, Hiball Energy, Redhook Brewery, Square Mile Cider, Widmer Brothers Brewing, Runner's High Brewing Company, Happy Flower, and Fresh Hemp Foods brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.